全球微泡/超音波造影劑市場規模、佔有率、成長分析、依疾病領域（心血管疾病、腎臟疾病）、依應用（分子影像、藥物傳遞）- 2024-2031 年產業預測

2022年全球微泡/超音波造影劑市場規模為18.7億美元，預計將從2023年的19.4億美元成長到2031年的26.6億美元，在預測期內（2024-2031年）複合年成長率為4.00億美元，在預測期內（2024-2031年）複合年成長率為4.00億美元，在預測期內（2024-2031年）複合年成長率為4.00億美元% 。

醫學影像中用於增強 X光下液體或結構可視性的物質（稱為造影劑或造影劑）通常對 X光是透明的。在對比超音波成像中，微泡在放射學和心臟病學中充當血池劑，在基因治療、藥物傳輸、分子成像和幹細胞傳輸中廣泛應用。這些微泡還可以透過與疾病特異性分子標記結合來發揮作用，提供一種有針對性的診斷手段。微泡的功能類似於靜脈注射時循環中的紅血球，在超音波脈衝下產生強烈的迴聲，由於其與周圍軟組織氣體的迴聲不同，透過放大超音波反射或反向散射來增強超音波心動圖的對比度。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依疾病領域分類的全球微泡/超音波造影劑市場

• 市場概況
• 心血管疾病
• 腎臟疾病
• 其他

全球微泡/超音波造影劑市場（依應用）

• 市場概況
• 分子影像
• 藥物輸送
• 基因治療
• 和幹細胞輸送

全球微泡/超音波造影劑市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2023 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率 (%), 2023

主要公司簡介

• General Electric Company
• Bracco Imaging SpA
• Lantheus Holdings, Inc.
• Daiichi Sankyo Company, Limited
• Bayer AG
• Fujifilm Holdings Corporation
• Sanofi SA
• Siemens Healthineers AG
• Guerbet Group
• nanoPET Pharma GmbH
• MBI Co., Ltd.
• Trivitron Healthcare
• Unilife Corporation
• PTW Freiburg GmbH
• Esaote SpA
• Mindray Medical International Limited
• Samsung Electronics Co., Ltd.
• Shimadzu Corporation
• Philips Healthcare
• Canon Medical Systems Corporation

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

A substance used in medical imaging to enhance the visibility of fluids or structures under X-rays, known as contrast media or contrast agent, is typically transparent to X-rays. In contrast ultrasound imaging, microbubbles serve as a blood pool agent in radiology and cardiology, finding extensive application in gene therapy, drug delivery, molecular imaging, and stem cell delivery. These microbubbles can also operate by binding to disease-specific molecular markers, offering a means of targeted diagnosis. Functioning akin to red blood cells in circulation upon intravenous injection, microbubbles generate strong echoes under ultrasound pulses, providing enhanced contrast in echocardiograms by amplifying ultrasound reflection or backscattering due to their differing echogenicity from surrounding soft tissue gases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segmental Analysis

Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of disease area, By application, and By Region. Whereas, Disease area is sub segmented into cardiovascular diseases, renal diseases, and others. By Application is sub segmented into the molecular imaging, drug delivery, gene therapy, and stem cells delivery. By Region is segmented on the basis of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Drivers of the Global Microbubbles/Ultrasound Contrast Agents Market

The utilization of microbubbles and ultrasound contrast agents in molecular imaging is increasingly fueled by the rising requirement for targeted therapies and the necessity to monitor biomarker status in vascular endothelium. Over the projected period, the market for microbubbles/ultrasound contrast agents is expected to grow, propelled by advancements in ultrasound technologies, escalating demand for targeted diagnostic instruments, the inherent advantages of microbubbles/ultrasound contrast agents compared to conventional diagnostic methods, and a surge in chronic disease prevalence.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

The global Microbubbles/Ultrasound Contrast Agents market faces a significant restraint due to the brief lifespan of microbubbles, hindering its growth prospects throughout the forecast period. Additionally, regulatory hurdles, limited reimbursement policies, and high manufacturing costs further impede market expansion, posing challenges to widespread adoption and innovation in ultrasound contrast agents.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

In the fields of cardiology and radiology, microbubbles are employed as blood-pool agents in contrast ultrasound imaging but are increasingly acknowledged for their promise as targeted agents in molecular imaging. By incorporating ligand molecules that attach to disease-specific molecular markers, microbubbles can be tailored for functionality. This enables the monitoring of biomarker status in vascular endothelium, visualization of tumor vasculature, and imaging of inflammation, ischemia-reperfusion injury zones, and thrombi, presenting diverse clinical applications for molecular imaging utilizing microbubble-based ultrasound contrast agents.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Microbubbles/Ultrasound Contrast Agents Market by Disease Area

• Market Overview
• cardiovascular diseases
• renal diseases
• and others

Global Microbubbles/Ultrasound Contrast Agents Market by Application

• Market Overview
• molecular imaging
• drug delivery
• gene therapy
• and stem cells delivery

Global Microbubbles/Ultrasound Contrast Agents Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• General Electric Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• nanoPET Pharma GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MBI Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unilife Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTW Freiburg GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote SpA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments